Search Results - Elghaity-Beckley, Sebastian

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Thrombocytopenia Associated with Myelofibrosis Is Characterized By a Reduced Proportion of Megakaryocyte (MK) Biased Hematopoietic Stem Cells, Defects in MK Maturation and Increased Levels of Pro-Inflammatory Cytokines

    Thrombocytopenia Associated with Myelofibrosis Is Characterized By a Reduced Proportion of Megakaryocyte (MK) Biased Hematopoietic Stem Cells, Defects in MK Maturation and Increase... by Varricchio, Lilian, Mosoyan, Gohar, Elghaity-beckley, Sebastian, Mascarenhas, John, Hoffman, Ronald

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells

    Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells by Clementelli, Cara, Mia, MD Babu, Haines, Sarah, Schaniel, Christoph, Olszewska, Malgorzata, Arandela, Joann, Elghaity-beckley, Sebastian, Klingborg, Sophie, Hoque, Zinedine, Lu, Min, Papapetrou, Eirini, Hoffman, Ronald, Marcellino, Bridget Kelly

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    An MDM2 degrader for treatment of acute leukemias

    An MDM2 degrader for treatment of acute leukemias by Marcellino, Bridget K., Yang, Xiaobao, Ümit Kaniskan, H., Brady, Claudia, Chen, He, Chen, Karie, Qiu, Xing, Clementelli, Cara, Herschbein, Lauren, Li, Zhijun, Elghaity-Beckley, Sebastian, Arandela, Joann, Kelly, Brianna, Hoffman, Ronald, Liu, Jing, Xiong, Yue, Jin, Jian, Shih, Alan H.

    Published in Leukemia
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

    TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms by Handa, Shivani, Amel Riazat-Kesh, Yosef Joseph Rene, Butterfield, Richard J, Sivakumar, Ganesh, Venugopal, Sangeetha, McGovern, Erin, Feld, Jonathan, Tremblay, Douglas, Elghaity-Beckley, Sebastian, Kremyanskaya, Marina, Mascarenhas, John O., Langlais, Blake, Mazza, Gina L., Nathan, Daniel I., Tripodi, Joseph, Najfeld, Vesna, Dueck, Amylou C, Rampal, Raajit, Hoffman, Ronald, Marcellino, Bridget Kelly

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Correction: An MDM2 degrader for treatment of acute leukemias

    Correction: An MDM2 degrader for treatment of acute leukemias by Marcellino, Bridget K., Yang, Xiaobao, Ümit Kaniskan, H., Brady, Claudia, Chen, He, Chen, Karie, Qiu, Xing, Clementelli, Cara, Herschbein, Lauren, Li, Zhijun, Elghaity-Beckley, Sebastian, Arandela, Joann, Kelly, Brianna, Hoffman, Ronald, Liu, Jing, Xiong, Yue, Jin, Jian, Shih, Alan H.

    Published in Leukemia
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: